CDKN2A and Alzheimer disease: A study conducted on mouse models of AD revealed that markers associated with cellular damage and cell cycle arrest, including p16, p21, and p53, as well as markers associated with inflammation, such as IL-6 and TNF-α, were found to be overexpressed [51].